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Based on Toll/interleukin-1 receptor (TIR) domain structure homology, we detected a previously uncharacterized gene encoding
for a TIR domain containing protein (Tcp) in the genome of Enterococcus faecalis. We assigned this gene the name tcpF (as in Tcp
of E. faecalis). Screening of E. faecalis samples revealed that tcpF is more common in isolates from urinary tract infections (UTIs)
than in human faecal flora. tcpF alleles showed moderate single nucleotide polymorphism (SNP) among UTI isolates. Infection of
mouse RAW264.7macrophages with a tcpF knock-outmutant led to elevated cytokine response compared to the isogenic wild type
E. faecalis strain. In silico analysis predicted significant tertiary structure homology to the TIR domain of human TLR1 (TLR1-TIR).
When transiently expressed in cultured eukaryotic cells, TcpF caused suppression of TLR2-dependent NF-𝜅B activation suggesting
for TcpF a role as a factor in E. faecalis that benefits colonization by modulating the host’s immune responses.
1. Introduction
Signaling via Toll-like receptors (TLRs) requires the homo- or
heterodimerization of the receptors. The process is initiated
by their extracellular leucine-rich repeats (LRRs) regions
and leads to dimerization of the receptor’s cytoplasmic
Toll/interleukin-1 receptor (TIR) domains which form a TIR-
TIR structure [1]. This TIR-TIR structure provides the site
of association with proteins of the TIR domain-containing
adapter family [2, 3]. Activation of TLR pathways leads to the
release of inflammatory cytokines like tumor necrosis factor
𝛼 (TNF-𝛼) and interleukin 6 (IL6), type I interferons (IFNs),
and chemokines, which in turn control the recruitment of
inflammatory cells to the infected tissues [4].
The central role of TLR signaling in innate immunity
makes it a target for bacterial induced immune subversion.
In 2006 the TIR-like protein, TlpA, from Salmonella enterica,
was reported as a novel prokaryotic modulator of NF-𝜅B
activity and interleukin 1 beta (IL-1𝛽) secretion that con-
tributes to serovar Enteritidis virulence by interfering with
TLR4 and MyD88 signaling [5]. Similar observations were
also made with the TIR domain containing proteins TcpC
of Escherichia coli and TcpB of Brucella melitensis [6]. TcpC
was found to impair the signaling of TLRs and the secretion
of proinflammatory cytokines IL6 and TNF-𝛼. Furthermore,
tcpC was associated with the severity of urinary tract infec-
tions (UTIs) [6]. It was demonstrated that the TIR domain
of TcpC was directly associated with MyD88 and TLR4 [7]
and TcpB targeted the Toll/IL-1 receptor domain-containing
adaptor protein (TIRAP) dependent pathway by mimick-
ing TIRAP’s affinity towards phosphatidylinositol phosphate
(PIP) resulting in inhibition of TLR2- and TLR4-mediated
signaling [8, 9]. Another TIR domain containing protein
Btp1 from Brucella abortus downmodulates maturation of
infected dendritic cells by interferingwith the TLR2 signaling
pathway [10]. Very recently a TcpC homolog protein (TirS) in
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Staphylococcus aureus was shown to attenuate TLR-induced
activation of NF-𝜅B and MAP-kinase signaling pathways in
vitro and contribute to organ colonisation upon S. aureus
infection in vivo [11]. The mechanism of bacteria interfering
with host TLR signaling by Tcps, by blocking endogenous
protein’s association, was described as molecular mimicry
[12].
We detected the sequence for a TIR domain contain-
ing protein in the genome of Enterococcus faecalis strain
Symbioflor 1 (GenBank: HF558530.1, Gene ID: EFS1 1683)
[13, 14]. The gene is also present in the published genomes
of E. faecalis V583 (GenBank: AE016830.1, EF 1959) and
Enterococcus sp. 7L76 draft genome (GenBank: FP929058).
We assigned this gene the name tcpF, in accordance with
the already described tcpC and tcpB. In this work we analyze
the distribution of tcpF among clinical E. faecalis isolates,
its genetic stability (allelic variation), the predicted protein
structure, and its impact on the cellular innate response to
infection.We report that tcpF wasmore frequent in E. faecalis
isolates from urinary tract infections (UTIs) than in human
faecal flora isolates. A tcpF deletion mutant of the model
strain E. faecalis Symbioflor 1 induced elevated cytokine
response upon infection of mouse macrophages compared
to the parental wild-type strain and transient expression of
TcpF in 293 human fibroblast cells led to suppression of the
TLR2 triggered NF-𝜅B activation. Both findings indicate a
role of TcpF in subversion of host defense by E. faecalis during
infection.
2. Materials and Methods
2.1. Alignments and Protein Structure Calculation. Mul-
tiple protein sequence alignments were generated using
Clustal Omega [15]. Protein tertiary structure prediction
was conducted via HHpred by the Max-Planck Insti-
tute for Developmental Biology. Superposition of protein
structures was done by TM-Align [16]. The structure of
TLR1-TIR (1FYV) was downloaded from the protein data
bank (http://www.rcsb.org/pdb/home/home.do). The pre-
sentations of the 3D TIR domain structures were accom-
plished by PyMOL software (http://www.pymol.org/).
2.2. Screening and Gene Sequencing. E. faecalis and E. coli
isolation was performed from urine samples of patients
with a clinically manifested UTI sent to the diagnostic
unit of the Institute of Medical Microbiology, University
Hospital Giessen and Marburg Ltd, branch Giessen. Colony
PCR for tcps screening was done by picking one bacterial
colony (ca. 105 bacteria) and using the following primers:
E. coli: UPECseq.1: 5󸀠 GAATGTTTTGGGCAACAATATG-3󸀠
and UPECseq.3: 5󸀠-TCTTCTCCTGTATGCTATTTCAGC-
3󸀠; E. faecalis: E.f.seq.1 and E.f.seq.2 (Table 1). PCR was
carried out for 30 cycles ((20 sec × 94∘C/30 sec × 55∘C/60 sec
× 72∘C) × 30/3min × 72∘C) with initial denaturation of
10min × 94∘C. An aliquot of the PCR was resolved on
0.8% agarose gel. The positive isolates were subjected to a
second PCR reaction in order to obtain DNA for sequencing
using the following primers: for E. coli sequencing: UPEC-
seq.6: 5󸀠-GTGGAAAACCTTCTATGCC-3󸀠, UPECseq.7: 5󸀠-
GTGGTAGTTATCTATACCCTACATCTG-3󸀠, and for E.
faecalis: E.f.seq.3 and E.f.seq.5 (Table 1). Resulting PCR frag-
ments were purified using the QIAquick PCR purification
Kit (Qiagen). Sequencing was done by AGOWA genomics,
Berlin (http://www.agowa.de/). The sequencing results were
analyzed with SeqManII (DNAStar) software. A second set
of 31 E. faecalis isolates was collected from stool samples of
non-UTI patients, where E. faecaliswas determined to be not
the cause of the illness, and screened for the presence of tcpF
as described above. Statistical analysis for the significance of
tcpF distribution among isolates was performed using Chi-
squared test [6].
2.3. Bacterial Strains. E. coli CFT073 (NC004431) was a kind
gift from U. Dobrindt, Institut fu¨r Molekulare Infektionsbi-
ologie, JMU Wu¨rzburg, Germany. E. faecalis Symbioflor 1
(DSM 16431) is a commercially available probiotic strain and
was provided by K. Zimmermann, SymbioPharm, Herborn,
Germany [13]. E. faecalis V583 was donated by J. Hu¨bner,
Division of Infectious Diseases, University Hospital Freiburg,
Germany. E. coli CFT073 (UPEC) was grown on Columbia
agar (Oxoid) or Luria-Bertani (LB) broth at 37∘C. E. faecalis
was grown in brain-heart-infusion (BHI) broth or on BHI
agar plates (Difco) at 37∘C. E. coli TOP 10 (Invitrogen)
was grown in Luria-Bertani (LB) broth at 37∘C on LB agar
plates (Difco). If required, antibiotics were added with the
following concentrations: ampicillin: 100 𝜇g/mL, kanamycin:
50 𝜇g/mL, and erythromycin: 10 𝜇g/mL for E. faecalis and
300 𝜇g/mL for E. coli. For infection assays E. faecalis were
grown in BHI broth to early exponential phase (OD
600
0.1–
0.5) and the bacterial concentration was calculated by optical
density from a standardized growth curve.
2.4. DNA Isolation and Manipulation. Genomic DNA from
E. coli and E. faecalis was isolated using the Genomic DNA
purification kit (Gentra). Plasmid preparations from E. coli
TOP 10 were done using the QIAfilter Plasmid Midi Kit
(Qiagen). Knock-out of the tcpF gene in the genome of E.
faecalis Symbioflor1 was done as described [17]. Briefly, the
flanking regions of the tcpF gene were amplified by PCR
(Expand High fidelity PCR system, Roche) using the primer
pairs Ef-Del-1A 5󸀠-AGCACTGGATCCGAACCAATTCTC-
CTTATACTCG-3󸀠 and Ef-Del-2 5󸀠-GACGACTACACA-
GTGCTCACTACTCAACATCCTCCA-3󸀠, giving rise to
a 345-bp product I, Ef-Del-3 5󸀠-ACTGTGTAGTCGTCG-
GTAGAGTAATTGGAGGAGGT-3󸀠, and Ef-Del-4 5󸀠-AGC-
AGTGAATTCAATGCAGCTGTTTCTAACAACCGA-3󸀠,
generating a 405-bp product II. A secondPCRwas performed
with primers Ef-Del-1A and Ef-Del-4 using both products
I and II as a template to amplify a 736-bp DNA fragment,
which was subsequently digested (BamHI and EcoRI), ligated
into the temperature sensitive shuttle vector pAULA (25),
and transformed into E. coli TOP10. The vector construct
was isolated, sequenced, and electroporated into E. faecalis to
achieve gene deletion.
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Table 1: RT and PCR primer for Enterococcus faecalis.
Primer Sequence 5󸀠 position
E.f.seq.1 5󸀠-GATGTTGAGTAGTGAGCAACG-3󸀠 −12 s
E.f.seq.2 5󸀠-CTCCTCCAATTACTCTACCTTCTC-3󸀠 832 as
E.f.seq.3 5󸀠-CCGTACATCGCTCTATAATCAC-3󸀠 −203 s
E.f.seq.5 5󸀠-GTCTAAATGCATCACTTTTAATTACTC-3󸀠 995 as
E.f.seq.6 5󸀠-AGCCATTCCAAAATAAACTGAC-3󸀠 470 s
E.f.seq.7 5󸀠-GAATTCCCGATTGTTATACG-3󸀠 770 as
E.f.seq.8 5󸀠-GCTTTCATCCTCTGATAGCGT-3󸀠 606 as
E.f.seq.14 5󸀠-AGTCATAGTTCAAAGGATCAAG-3󸀠 29 s
E.f.seq.15 5󸀠-CTGATCATTATTATCAGAGTATTCCATG-3󸀠 212 s
E.f.seq.17a 5󸀠-GTAGTGAGCAACGGGAAAAAGAT-3󸀠 −3 s
s: sense.
as: antisense.
TcpF and tcpCwere cloned into the eukaryotic expression
plasmid pCMV-Flag-2B (Stratagene), generating the plas-
mids pSty10 (TcpF) and pSty13 (TcpC1).The following primer
combinations were used to amplify genomic DNA for the
cloning: TK9: 5󸀠-ACTACTGGTCTCAGCGCCAATGAG-
AGTATCAGT-3󸀠 and TK10: 5󸀠-ACGACTGGTCTCATA-
TCAGATAAATAATTTAACTGGCT-3󸀠 for E. faecalis TcpF
(pSty10); pTcpC-Flag For: 5󸀠-ATCCGCGGATCCATAGCA-
TATGAAAACATAGAATTT-3󸀠 and pTcpC-Flag Rev: 5󸀠-
GCGAGTCTCGAGTTATCTTCTCCTGTATGCTATTTC-
AGC-3󸀠 [6] for full length E. coli tcpC (TcpC1) originally a
GTG start codon (pSty13).The vector and the amplified DNA
fragments were cut with BamHI and XhoI (Fermentas) in
order to prepare compatible cohesive ends for ligation.
2.5. RNA Isolation and RT-PCR. For RNA isolation, E.
faecalis Symbioflor 1 and V583 were harvested after growth
in BHI broth or from the cell culture supernatants (DMEM)
of CaCo cells after 1, 2, or 3 h of infection. Total RNA was
isolated using the RNeasy Protect Bacteria Mini Kit (Qiagen)
following the manufacturers’ protocol with lysozyme lysis.
The RNA was eluted in RNase free water, digested with 2U
of Turbo DNaseI (Ambion) for 30min at 37∘C, and again
purified using the RNeasy Mini Kit (Qiagen). RNA was
recovered in RNase free water, heat denatured for 10min
at 65∘C, and quantified with the NanoDrop ND-1000 UV-
Vis Spectrophotometer (NanoDrop Technologies), and a
quality profile with the Agilent 2100 bioanalyzer (Agilent
Technologies) was made. For RT-PCR, 400 ng total RNA
was reverse transcribed using 50U Superscript II Reverse
Transcriptase (Life Technologies) in a 20 𝜇L reaction using
primers E.f.seq. 7 or E.f.seq. 2 (Table 1) following the instruc-
tions of the manufacturer. PCR was done with 3 𝜇L of first
strand cDNA in a 30 𝜇L reaction using 1U Taq Polymerase
(Life Technologies). PCRwas carried out for 30 cycles ((20 sec
× 94∘C/30 sec × 53–56∘C/60 sec × 72∘C) × 30/3min × 72∘C).
8 𝜇L of the PCR reaction was resolved on 1.5% agarose gels.
2.6. Luciferase Reporter Assay. Human TLR2 and luciferase
expressing plasmids are described previously [18]. Confluent
overnight cultures of HEK 293 cells in 12-well plates, grown
in DMEM (Gibco) supplemented with 10% foetal calf serum
(PAA Laboratories) and 1x penicillin/streptomycin (Gibco),
were washed in DMEM and transfected with a mixture of
2.4 𝜇g plasmid DNA and 7 𝜇L Lipofectamine 2000 (Invit-
rogen). All assays were performed with a constant amount
of reporter constructs as follows: 550 ng pELAM-Luc and
50 ng phRL-TK (Promega), 50 ng phTLR2, and increasing
amounts of TcpC1 (50 ng to 1550 ng of pSty13) or TcpF
(50 ng to 1550 ng of pSty10). DNA to Lipofectamine ratio was
kept stable by using the empty CMV-promoter vector pRK5
(BD Pharmingen). After 6 h the medium was replaced with
DMEM supplemented with 10% FCS and after an additional
2 h, the cells were split, transferred to 96-well plates at 4 ×
104/well, and incubated overnight in DMEM supplemented
with 5% FCS. On the next day the cells were stimulated with
0.5 𝜇M Pam
3
Cys-SKKKK × 3 HCl (EMC microcollections
GmbH, Tu¨bingen) in DMEM. Control samples were treated
with an equal volume of DMEM. Stimulated cells were
incubated for 5 h, lysed afterwards with 20𝜇L Passive Lysis
Buffer (Promega), and stored at −20∘C. Measurement of NF-
𝜅Bmediated luciferase activity was carried out with theDual-
Luciferase Reporter Assay System (Promega) using an L-max
plate reader (Molecular Devices). Signal measurements were
performed in triplicate and experiments were repeated at
least three times. The primary firefly luciferase signal was
normalized to the signal of Renilla luciferase in each well,
resulting in relative luciferase activity. Results are presented
as fold changes of stimulated to nonstimulated activity.
2.7. Cytokine Assays. RAW 264.7 mouse macrophages were
seeded on 24-well plates at 6× 105 cells/well in 500𝜇LDMEM
supplemented with 10% FCS and 1x penicillin/streptomycin.
On the next day the cells were washed twice with PBS (37∘C)
and covered with 400𝜇L DMEM + 1% FCS. The RAW 264.7
cells of two control wells were harvested and counted in order
to define exact cell numbers. 100 𝜇L bacterial suspension in
DMEM, containing a defined CFU number, was added to the
cells and incubated for 5 h. Supernatants were collected from
cells infected with E. faecalis Symbioflor 1 and the isogenic
ΔtcpF mutant. The secretion of TNF-𝛼 was measured using
the mouse TNF-𝛼 Quantikine ELISA kit (BD) on a Phomo
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Plate reader (Anthos Mikrosystme) according to the kits
manual.
3. Results
3.1. In Silico Modeling of TcpF. In a database search of bac-
terial genomes using conserved domain database (CDD) on
NCBI, we identified a gene encoding for a TIR domain con-
taining protein in the genome ofE. faecalis strain Symbioflor 1
(Gene ID: EFS1 1683).The sequence spans 825 base pairs cod-
ing for a 274-amino-acid-long protein with predicted mass of
32650Da. Concordant with previous studies [6], we assigned
this gene the name TIR domain containing protein of E. fae-
calis (tcpF). Additionally, a multiple primary sequence align-
ment of the human TIR domain containing proteins involved
in TLR2 signaling, TLR1, TLR2, MyD88, and MAL, and the
bacterial TIR domain containing proteins PdTLP, TcpC, and
TcpF [12] revealed strong consensus in the Box1 motif [19],
the last two residues, proline (P) and glycine (G), of the Box2
motif, and the residues forming the 𝛽C-strand and the 𝛼C-
helix (Supplementary Figure 1 in Supplementary Material
available online at http://dx.doi.org/10.1155/2014/918143).The
primary sequence of TcpF-TIR exhibits commonTIR domain
motifs. The predicted tertiary structure of TcpF-TIR shows a
typical TIR domain fold with parallel 𝛽-strands surrounded
by 𝛼-helices and loops (Supplementary Figure 2(a) In silico
structure prediction of TcpF-TIR reveals structural similarity
to TLR1-TIR.). The TIR domain of TcpF is located at the N-
terminus and consists of 4 𝛽-strands, which are coated by
4 𝛼-helices. The superposition of TcpF-TIR and TLR1-TIR
reveals considerable similarity between those two structures
(Supplementary Figure 2(b)). In particular, strong similarity
can be observed at the BB-loop,which has been reported to be
part of the interface of TLR1-TIR and TLR2-TIR interaction
(Supplementary Figure 2(c)) [20]. Also located at the C-
terminus of TcpF, we found the motif KVRFKLKK similar
to a functional motif in TcpB of Brucella, a PIP2 binding
domain with the basic amino acid sequence KKRxxxxKK.
It was reported that this motif promotes colocalization with
the plasma membrane of the eukaryotic cell by binding to
membrane phosphoinositides [9].
3.2. Screening of E. faecalis Strains for tcpF. A total of 110 urine
isolates of patients with clinically diagnosedUTI and 31 faecal
flora E. faecalis isolates were screened via PCR with primers
E.f.seq.1 and E.f.seq.2 positioned at the start and the end of
the tcpF open reading frame (ORF). The UTI isolates were
collected in a period of three months from samples sent to
the microbiology diagnostic lab of the Institute of Medical
Microbiology. The samples originate from patients admitted
to the University Hospital in Giessen with clinically apparent
UTI. Among UTI samples, E. faecalis colony-forming unit
(CFU) numbers varied with respect to the threshold of
<105/mL and >105/mL; the latter fulfill the microbiological
definition of UTI. E. faecalis stool isolates were derived from
stool samples of non-UTI patients, where E. faecalis was
determined as not the causative agent, but element of the stool
commensal flora. TcpF was found in 76.4% of all UTI isolates.
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Figure 1: TcpF frequency among UTI and commensal isolates. TcpF
is associated with cfu > 10e5/mL upon infection of the urinary tract
by E. faecalis. TcpF was detected by PCR. Commensals 𝑛 = 31, UTI
> 10e5cfu/mL, 𝑛 = 68 (∗𝑃 = 0,028), UTI < 10e5cfu/mL 𝑛 = 42.
Statistical analysis was performed using Chi-squared test.
Interestingly, tcpF was present in 79.4% of UTI isolates
from samples with CFU numbers > 105/mL but was less
common in UTI isolates from samples with CFU numbers <
105/mL (71.4%) or isolates from faecal flora (58.1%) (Figure 1).
These numbers suggest that the presence of tcpF benefits the
colonization of the human urinary tract (UT) and promotes
E. faecalis survival.
3.3. Genetic Analysis of tcpF. We further examined the
genetic stability of tcpF among urine isolates by sequencing
the target gene and the neighboring regions. A PCR with
primers E.f.seq.3 and E.f.seq.5 was done for a total of 68
isolates including isolates from urine samples with more
than 105 CFU/mL (𝑛 = 44) and less than 105 CFU/mL
(𝑛 = 22). The primers are located about 150–200 bp up- and
downstream from the tcpF gene.The amplified PCR fragment
has an expected length of 1206 bp. Primers E.f.seq.3 and
E.f.seq.5 were reused for bidirectional sequencing. The SNPs
aligned to the tcpF sequence of E. faecalis Symbioflor 1 are
shown in Figure 2(a). In total, we identified 18 tcpF genotypes
and found four nucleotide substitutions leading to amino acid
changes.The transitionG121Awas themost frequent (85.3%);
thus it seems to be themore stable variant.This SNP is located
within the TIR domain and leads to the change of alanine to
threonine. The transversion C226G is located also within the
TIR domain resulting in a glutamine to lysine exchange. Only
one strain showed this substitution. The transitions C551T
and T809C are outside of the TIR domain. C551T results
in a threonine to isoleucine exchange and was found in 40
tcpF positive isolates (58.8%). T809Cwas found in one isolate
and results in leucine to serine exchange. The G121A and
C551Talleles were randomly distributed among the isolates
from urine samples with CFU > 105/mL and CFU < 105/mL.
Two E. faecalis urine isolates produced PCR fragments
of unexpected length suggesting a larger insertion within
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Figure 2: TcpF’s sequence polymorphism. (a) SNP frequency in the tcpF locus of 68 E. faecalis UTI isolates. Sequence alignment was
conducted on tcpF of E. faecalis Symbioflor 1. Black bars indicate mutations resulting in amino acid substitutions and white bars indicate
silentmutations.The amino acid substitutions are G121A: Ala-Thr, C226G: Gln-Lys, C551T:Thr-Ile, and T809C: Leu-Ser. (b) Genetic structure
of the tcpF locus of E. faecalis isolates. Two major rearrangements were observed in the UTI isolates E. faecalis #53 and #31. P1/P2: primer
positions for the screening-PCR; P3/P4: primer positions for the sequencing-PCR.
the primers’ positions (Figure 2(b)). Isolate E.f.#53 yielded
the expected fragment of 844 bp in the screening PCR.
However, the sequencing PCR produced a fragment of about
2000 bp by expected 1206 bp.The sequencing revealed a 5󸀠end
insertion followed by the open reading frame of tcpF. The
search in the genome of E. faecalis Symbioflor 1 showed
this inserted sequence to encode for a gene with annotated
transposase function (EFS1 1430). Isolate E.f.#31 produced
a fragment of unexpected length in the screening as well
as in the sequencing PCR. The amplified fragment of the
screening PCR was about 1800 bp and the fragment of the
sequencing PCR was about 2100 bp, revealing that the ORF
of tcpF was disrupted by an inserted fragment. A genomic
BLAST search identified a homolog sequence in the genome
of E. faecalis V538 encoding for the gene downstream of
tcpF with annotated putative deoxyguanosine triphosphate
triphosphohydrolase (GTPase) function (EF 1958). In both,
the genomes of E. faecalis Symbioflor 1 and V538, the putative
GTPase gene starts in close proximity (17 bp) to the 3󸀠end of
tcpF.
In order to compare tcpF’s genetic variation to other
bacterial tcps we screened 100 E. coli isolates derived from
urine specimens of UTI patients for the presence of the
tcpC sequence. All isolates originated from samples with
CFU numbers > 105/mL. 20 E. coli isolates (20%) were
tcpC positive. Unlike tcpF, sequencing of tcpC revealed very
low genetic polymorphism. The sequence of 19 isolates was
identical toCFT073’s tcpC. One isolate only showed two point
mutations. The transition G385A led to an alanine to valine
exchange, whereas the transition C482T was silent.
The transcription of tcpF mRNA was verified for E.
faecalis Symbioflor 1 (Figure 3(a)) aswell as for the pathogenic
isolate V583 (data not shown). cDNA transcripts with
increasing length were observed using reverse transcription
primer E.f.seq.2 positioned between base pairs 809 and 832
(stop codon TAA at 823–825 bp), and PCR with primers
which span the length of the gene up to the start codon. TcpF
was transcribed during growth of bacteria in BHI medium
and also by coincubation (infection) with colon carcinoma
CaCo-2 cells for up to three hours (Figure 3(b)).
3.4. Functional Analysis of TcpF. In order to analyze the
function of TcpF during infection, we created a tcpF deletion
mutant of the model strain E. faecalis Symbioflor 1 = Sym-
bioflor 1 ΔtcpF. The deletion did not affect bacterial growth
in BHI medium (Figure 4(a)), but infection of mouse RAW
264.7 macrophages with the deletion mutant led to signifi-
cantly higher TNF-𝛼 secretion in medium than that caused
by the wild-type strain Symbioflor 1 (Figure 4(b)), revealing
inhibition of stress signaling by TcpF. Further studies should
include infection experiments of mouse macrophages with a
complemented strain (E. faecalis Symbioflor ΔtcpF + tcpF)
in order to additionally support and verify the knock-out
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identical growth rate. Fresh culture was started from overnight culture 1 : 25 in BHI at 37∘C and 100 rpm. Optical density at 600 nm (OD
600
)
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phenotype and gene function. Previous studies have shown
that immune suppression by bacterial Tcps is based on direct
interaction with host’s Tcps leading to interference with
TLR signaling [6, 7, 11]. TLR2 is responsible for sensing
Gram-positive pathogens [18]; hence we expressed cloned
TcpF and TcpC in human fibroblast cells and monitored the
effect on the TLR2 dependent NF-𝜅B activation. Therefore,
HEK293 cells were transiently transfected with plasmids
expressing the firefly luciferase gene under the control of
an NF-𝜅B dependent promoter (pELAM-Luc) and plasmids
constitutively expressing human TLR2 (phTLR2). Plasmids
for constitutive eukaryotic expression of Tcps : pSty10 (TcpF)
or pSty13 (TcpC of UPEC CFT073) were cotransfected in
a ratio of 1 : 1, 1 : 2, 1 : 5, 1 : 10, and 1 : 31 to phTLR2. Trans-
fected cells were stimulated with Pam
3,
a synthetic ligand
of TLR2. Intracellular expression of TcpF resulted in dose
dependent NF-𝜅B signal suppression comparable to that of
TcpC (Figure 5). These results suggest that TcpF interferes
with TLR signaling in a similar manner to TcpC [6] resulting
in markedly reduced cytokine release and impaired response
upon infection.
4. Discussion
Over the last decade several bacterial TIR domain-containing
proteins (Tcps) have been identified [21], yet all but one
were found in Gram-negative bacteria [11]. Using a con-
served protein domain search we discovered a homologous
sequence for the TIR domain encoded by a gene of previously
unknown function in the genome of E. faecalis (E. faecalis
V583: EF 1959; E. faecalis Symbioflor 1: EFS1 1683) [13, 14].
Enterococci have until recently been considered harmless or
even beneficial commensals of the gastrointestinal tract, the
oral cavity, and vagina in humans. However, there is growing
evidence that these bacteria possess specific traits that enable
them to colonize new habitats in the host and cause infections
such as bacteremia, peritonitis, endocarditis, device-related
infections, and urinary tract and wound infections [22].
Enterococci, and particularly the species E. faecalis, are second
to E. coli to cause UTIs [23].
In a screening of UTI and stool isolates, we found that
the TIR containing gene, tcpF, is less frequent in commensal
E. faecalis strains (58.1%) than in isolates from UTI (76.4%)
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Figure 5: Intracellular expression of TcpF impairs TLR2 dependent NF𝜅B activation. HEK293 cells were transiently transfected with hTLR2
(50 ng), pRK5, reporter plasmids pELAM-Luc and phRL-TK, and increasing amounts of TcpF (a) or TcpC1 (b) expressing plasmids at ratios of
1 : 1, 1 : 2, 1 : 5, 1 : 10, and 1 : 31. Cells were stimulated with 0.2 𝜇MPAM3 and incubated for 5 h. Nonstimulated and TLR2 deficient cells (TLR2-)
served as controls. Error bars represent s.d. (𝑛 = 3). RLU: relative luciferase unit.
and this difference becomes more significant when only the
UTI isolates with cfu numbers higher than 10e5/mL (79.4%
tcpF positive) are compared with the commensals (𝑃 =
0.028) (Figure 1), suggesting that the tcpF promotes bacterial
survival and therefore constitutes a selective advantage for the
colonization of the human UT by E. faecalis. Similar obser-
vations were made by Cirl et al. 2008 [6] regarding the TIR
domain containing protein of E. coli (TcpC). They reported
that TcpC promotes intracellular survival in immune and
epithelial cells and that tcpC was associated with severity of
UTI in humans. In their study tcpC was found in 40% of
acute pyelonephritis isolates but was less common in cystitis
(21%), asymptomatic bacteriuria (16%), or commensal (8%)
E. coli strains. Interestingly, we found tcpF to be also abundant
(58.1%) among commensal (nonpathogenic) isolates from
faecal flora, indicating a stronger beneficial effect of the
Tcp gene for E. faecalis than that for E. coli (8%) in the
colonization of the human GI tract.
The sequence analysis of tcpC revealed just one point
mutationwith a subsequent amino acid change and one silent
point mutation among 20 tcpC positive E. coli isolates. Both
nucleotide substitutions do not concern the TIR domain.
However, in the 825 bp long sequence of tcpF we detected
point mutations in 20 positions and 4 of them resulted in
subsequent amino acid changes. Two of them are within the
TIR domain, yet one of them C226G is of very low frequency
(1 in 68). Thus, in contrast to tcpC, tcpF shows a moderate
genetic polymorphism, which however translates only to a
lower extent in primary amino acid sequence variation. In
silico modeling of the TIR domain of TcpF reveals a con-
served (stable) amino acid sequence resulting in conserved
secondary and tertiary structures (Supplementary Figure
2(a)). The observed alteration Ala41Thr leads to structural
changes in the beginning of the BB-loop (Supplementary
Figure 2(d)), whereas the alteration Gln76Lys does not
influence the TIR domain structure (Supplementary Figure
2(e)). Whether Ala41Thr affects binding towards possible
binding partners is a matter of speculation, which requires
further experiments, for example, TLR2 coexpression, to
provide a definite answer. Remarkably, we observed also
two major insertions in this gene locus among the isolated
strains. In the case of E.f.#53 a transposition led to alteration
of the neighboring sequence of tcpF. In the case of E.f.#31,
an insertion of the downstream positioned GTPase gene
into the tcpF ORF took place, most probably the result
of an inversion (Figure 2(b)). It appears that the GTPase
(EFS1 1682; EF 1958) was part of the insertion loop and
was rearranged into the tcpF gene, based on the known
insertion mechanisms [24]. Both locus rearrangements and
also the higher number of single nucleotide polymorphisms
in tcpF compared to tcpC support the hypothesis of a process
of ongoing selection and a more recent acquisition of the
sequence in the genome of E. faecalis. Interestingly, in all tcpF
positive isolates tcpF is always paired with the downstream
positioned putative GTPase gene. However, no functional
dependency or interrelationship between both genes has been
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reported yet or was predicted when comparing homologous
protein domains in other bacteria. Both genes are not part
of any known cluster being positioned 350 bp away from
the next upstream and 630 bp from the next downstream
neighbor.
Bacterial Tcps have been postulated to modulate host
immune response by interference with the TLR signal-
ing pathway [11, 12]. Using the mouse macrophage line
RAW264.7 to investigate the effect of TcpF on host immune
cells, we found that infection with the tcpF deletion mutant
of E. faecalis strainSymbioflor 1 led to significantly higher
TNF-𝛼 response as compared to wild-type (Figure 4(b)).
TNF-𝛼 promotes the acute phase reaction and leads to the
recruitment of inflammatory cells [4]. Our results show that
TcpF enables E. faecalis to attenuate host’s cytokine response
upon infection to avoid elimination by immune cells. Finally,
the ability to suppress the TLR2 dependent NF-𝜅B activation
for TcpF was shown to be similar to the suppression caused
by TcpC as demonstrated by Cirl et al. 2008 [6]. TLR2’s main
ligands are bacterial lipoproteins allowing the receptor to
react by stimuli from bothGram-positive andGram-negative
bacteria [3]. The intracellular expression of TcpF suppressed
the TLR2 dependent NF-𝜅B signal in a dose dependent man-
ner (Figure 5). Considering molecular mimicry of human
TIR domains as the mechanism for the immune modulatory
effect of bacterial TIR containing domain proteins, TcpF’s
possible targets in the TLR2 dependent pathway are the
TIR domains of TLR2, TLR1, TLR6, and MyD88 as well as
MAL [4]. The structure prediction revealed that TcpF-TIR
shows high similarity to TLR1-TIR. Since the BB-loop of
TLR1-TIR and in particular the Gly 49 within the BB-loop
(Supplementary Figure 2(c)) were shown to be involved in
TLR1-TIR and TLR2-TIR interaction [20], it seems likely that
TcpF may compete with the TIR domain of human TLR1 for
TLR dimer formation and so abolishes further downstream
signaling. In this context a colocalization of TcpF with the
cytoplasmic part of TLRsmay be facilitated by the presence of
the KVRFKLKKmotif at the C-terminus of TcpF as reported
for the KKRxxxxKK motif in TcpB of Brucella [9].
In spite of their pathogenic potential, enterococci are
exemplary commensals as evidenced by their presence as
natural colonizers of the GI tract and by the fact that
they have been used safely for decades as probiotics [13,
25]. Avoiding activation of NF-𝜅B via TLR inhibition is
crucial for homeostasis in the GI tract, where epithelial cells
are in constant contact with the commensal microbiota.
Accordingly, inhibitory molecules that minimize the risk
of perpetual activation, such as the TLR inhibitors PPARy,
A20, NOD2, IRAK-M, SIGIRR, and Tollip, are essential
for sustaining mucosal homeostasis in the human gut [26].
Inappropriate activation of TLR signaling pathways leads to
deleterious inflammation and has been implicated in the
pathogenesis of GI disorders, including inflammatory bowel
disease [27] and colon cancer [28]. On account of the higher
frequency of polymorphisms detected in the tcpF ORF, this
gene’s acquisition appears to be a relatively recent event for
the genome of E. faecalis. This gene seems to be beneficial
for the colonization of the UTI tract by Enterococcus faecalis
since 79% of UTI isolates with CFU numbers > 105/mL
carry this gene and even 71.4% of the UTI isolates with CFU
numbers < 105/mL are also positive for the gene. On the
other hand, the gene is also present in more than the half
of commensal isolates from stool samples; thus this recently
acquired gene is spreading successfully among commensal
E. faecalis strains, also indicating a positive effect for the
colonizing bacteria in the gut. In both the pathogenic and
commensal strains, the presence of tcpF serves the paradigm
of attenuating TLR2 signaling, therefore limiting bacterial
recognition and immune activation by the host and therefore
enabling colonizing bacteria to reach higher cfu numbers. It
appears that TcpF promotes E. faecalis invasion and survival
in the UTI and while in its natural polymicrobial habitat, the
human GI tract, TcpF benefits the intestinal homeostasis.
5. Conclusion
In this work we provide evidence that TcpF from E. faecalis is
a newmember of the family of bacterial Tcps in the phylumof
Gram-positive bacteria. In silico structure prediction of TcpF-
TIR showed a characteristic TIR domain fold and strong
similarity to TLR1-TIR in particular. A screening of UTI
isolates of E. faecalis revealed that tcpF is more frequent
among isolates of human urinary tract infections than stool
flora, particularly in isolates with bacterial counts of more
than 10e5 cfu/mL (𝑃 = 0.028). In vitro, TcpF was shown to
impair the secretion of proinflammatory cytokines during
infection of host cells and to interfere with TLR2 signaling
upon intracellular expression, supporting the concept of
molecularmimicry, as imposed to this group of proteins. Due
to TcpF’s ability to negatively modulate recognition by the
TLR2 receptor and NF-𝜅B activation and the fact that tcpF
not only is common among E. faecalis isolates from intestinal
flora but even prevails among human UTI isolates (Figure 1),
it appears that tcpF represents a recently acquired adaptive
feature for E. faecalis that favors UT invasion and generally
benefits mucosa colonization.
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